This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Australian New Zealand Clinical Trials Registry | |
|---|---|
| Name | Australian New Zealand Clinical Trials Registry |
| Abbreviation | ANZCTR |
| Country | Australia, New Zealand |
| Established | 2005 |
Australian New Zealand Clinical Trials Registry
The Australian New Zealand Clinical Trials Registry is a publicly accessible registry for clinical trials conducted in Australia and New Zealand, serving as a repository of trial protocols, registration metadata, and status updates linked to ethical oversight and publication. It provides registration for interventional and observational studies and interfaces with international platforms to support transparency in trial conduct and reporting. The registry connects trial information with institutional review pathways, research governance frameworks, and publication standards across the region.
The registry collects trial records from principal investigators at institutions such as University of Sydney, University of Melbourne, Auckland District Health Board, University of Otago, Monash University, and Griffith University. It interoperates with international initiatives like World Health Organization, International Committee of Medical Journal Editors, ClinicalTrials.gov, European Union Clinical Trials Register, and WHO International Clinical Trials Registry Platform to meet global disclosure norms. Key stakeholders include research funders such as National Health and Medical Research Council, Health Research Council of New Zealand, and regulatory bodies like the Therapeutic Goods Administration and Medsafe. The registry supports linkage to publication venues including The Lancet, New England Journal of Medicine, BMJ, Nature Medicine, and PLOS Medicine.
The registry was established amid international calls for trial registration from actors like World Health Organization, advocates from AllTrials campaign, and editors of The BMJ and New England Journal of Medicine. Early development involved collaborations with Australian research networks including Australian National University, CSIRO, and New Zealand research bodies such as University of Auckland. Landmark events influencing growth include the adoption of ICMJE registration requirements at the International Committee of Medical Journal Editors meeting and policy reforms by National Health and Medical Research Council and Health Research Council of New Zealand. Over time the registry incorporated digital infrastructure influenced by standards developed at NIH and data models resonant with European Medicines Agency initiatives.
Investigators from facilities like Royal Prince Alfred Hospital, St Vincent's Hospital, Sydney, Christchurch Hospital, and universities such as University of Western Australia submit protocol-level data, ethics approvals, and contact details. The registry enforces policies aligned with International Committee of Medical Journal Editors and World Health Organization minimum dataset elements, requiring disclosure of outcomes, interventions, and trial phase akin to systems used by ClinicalTrials.gov and EudraCT. It provides processes for prospective registration prior to participant enrollment, amendments reporting, and trial completion notifications compatible with publisher policies at journals such as The Lancet Oncology and Journal of Clinical Oncology. Sanctioning and data removal protocols are coordinated with institutions including Royal Australasian College of Physicians and research integrity offices at University of Queensland.
Data curation employs structured fields mapped to terminology standards influenced by ICD-10, SNOMED CT, and metadata practices advocated by FAIR principles adopters at organizations like Australian Research Data Commons. Quality assurance includes manual review by registry staff trained in clinical research regulations, cross-checks with ethics committees including Human Research Ethics Committee (HREC) networks, and validation against sponsor documentation from corporations such as CSL Limited and contract research organizations used by Pfizer and GlaxoSmithKline. Version control and audit trails echo systems implemented by NIH ClinicalTrials.gov and data governance frameworks from Australian Digital Health Agency.
Governance involves representatives from universities, research institutes, and health agencies such as Australian Government Department of Health and Aged Care, Ministry of Health (New Zealand), and funders like National Health and Medical Research Council and Health Research Council of New Zealand. Funding streams have combined public support, institutional contributions, and partnerships with entities similar to Medical Research Future Fund models. Advisory input has come from professional colleges including Royal Australasian College of Surgeons, consumer groups analogous to Health Consumers Queensland, and publishers including Wiley and Elsevier on transparency standards.
Researchers at Walter and Eliza Hall Institute, clinicians at Royal Hobart Hospital, and trial sponsors utilize the registry for recruitment visibility, ethical compliance evidence, and linkage to systematic review sources like Cochrane. The registry has been cited in policy dialogues by World Health Organization and influenced journal editorial practices at BMJ Open and PLOS ONE. It supports meta-research by academics at University of Oxford, Harvard University, and Johns Hopkins University who assess outcome reporting bias, trial discontinuation, and reproducibility. Public health agencies such as Australian Institute of Health and Welfare use registry data for surveillance of clinical research activity.
The public interface enables searches by condition terms used at institutions like Peter MacCallum Cancer Centre and filters by recruitment status, intervention type, and sponsor names akin to capabilities found on ClinicalTrials.gov and EU Clinical Trials Register. The platform supports export formats compatible with data aggregators at WHO ICTRP and research infrastructures like Dryad and Figshare. Accessibility features align with national digital standards from Australian Digital Health Agency and regional usability guidance from New Zealand Government Web Standards to facilitate use by clinicians, patients, and systematic reviewers.
Category:Clinical trial registries